ACTISOUFRE 4 mg/50 mg per 10 ml, oral suspension or nasal drops 30 ampoules of 10 ml
Active ingredients: Saccharomyces cerevisiae, SODIUM (MONOSULFURE DE) NONAHYDRATÉ
Commercialized according to BDPM
Oral suspension or for instillation30 ampoules of 10 mlnasale;orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACTISOUFRE 4 mg/50 mg par 10 ml, suspension buvable ou pour instillation nasale
- Pharmaceutical form
- suspension buvable ou pour instillation
- Route of administration
- nasale;orale
- Presentation description
- 30 ampoule(s) en verre brun de 10 ml
- Marketing authorisation holder
- GRIMBERG
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Jun 1988
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66047164CIP73281643CIP133400932816439Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (MONOSULFURE DE) NONAHYDRATÉsuspension | 4 mg · une ampoule de 10 ml | SA |
| SACCHAROMYCES CEREVISIAEsuspension | 50 mg · 10 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.